Diclazuril antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Diclazuril antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-41-1 | 1. BSA-Diclazuril 2. Anti-Diclazuril mouse monoclonal antibody | $2709.00 |
GMP-SMT-41-2 | 1. OVA-Diclazuril 2. Anti-Diclazuril mouse monoclonal antibody | $2709.00 |
GMP-SMT-41-3 | 1. BSA-Diclazuril 2. Anti-Diclazuril human monoclonal antibody | $2709.00 |
GMP-SMT-41-4 | 1. OVA-Diclazuril 2. Anti-Diclazuril human monoclonal antibody | $2709.00 |
GMP-SMT-41-Ag-1 | BSA-Diclazuril | $756.00 |
GMP-SMT-41-Ag-2 | OVA-Diclazuril | $756.00 |
GMP-SMT-41-Ab-1 | Anti-Diclazuril mouse monoclonal antibody | $1953.00 |
GMP-SMT-41-Ab-2 | Anti-Diclazuril human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Diclazuril
Cat No. | GMP-SMT-41-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Diclazuril with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Diclazuril had been validated with our anti-Hapten antibody Anti-Diclazuril mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Diclazuril
Cat No. | GMP-SMT-41-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Diclazuril with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Diclazuril had been validated with our anti-Hapten antibody Anti-Diclazuril mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Diclazuril mouse monoclonal antibody
Cat No. | GMP-SMT-41-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 1-1.5 |
Products description | The anti-Hapten antibody against hapten Diclazuril had been validated with our hapten hapten-carrier conjugates BSA-Diclazuril via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Diclazuril human monoclonal antibody
Cat No. | GMP-SMT-41-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 1-1.5 |
Products description | The anti-Hapten antibody against hapten Diclazuril had been validated with our hapten hapten-carrier conjugates BSA-Diclazuril via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. What is Diclazuril, and What is Its Role in Veterinary Drug Residues and Additives?
Diclazuril, known by its systematic chemical name 4-chlorophenyl [2,6-dichloro-4-(3,5-dimethyl-2-pyridyloxy)phenyl] methoxyacetate, is a potent and widely recognized triazine compound in the field of veterinary pharmacology. Its unique chemical structure and mechanism of action make it invaluable in the realm of veterinary medicine, specifically in the prophylaxis and management of a parasitic disease known as coccidiosis.
Coccidiosis is caused by protozoan parasites belonging to the Eimeria genus, which inflicts harm on a broad range of animal species, most notably poultry and livestock. The disease can lead to significant economic losses through reduced animal growth, impaired production, and increased mortality rates. Diclazuril, as a coccidiostat, plays a pivotal role in safeguarding animal health and welfare by preventing and controlling coccidiosis.
The mechanism of action of Diclazuril involves inhibiting the development of coccidian parasites. It interferes with the formation of sporozoites within the host's body, thereby impeding the parasite's life cycle and reducing the harmful effects of coccidiosis. This action helps to mitigate the economic impact of coccidiosis on the livestock and poultry industry, as well as improve animal welfare.
Beyond its role in preventing coccidiosis, Diclazuril is instrumental in the broader context of food safety and quality assurance. As animals treated with Diclazuril produce meat, milk, and eggs, the residues of this compound can potentially be present in these animal-derived products. Consequently, the accurate measurement and monitoring of Diclazuril residues are essential to ensure that these products meet stringent safety standards and regulatory requirements.
Diclazuril is considered a veterinary drug, and its residues must conform to established limits to guarantee the safety of human consumption. Regulatory bodies worldwide have set maximum residue limits (MRLs) for Diclazuril in various food products, which need to be strictly adhered to. The continuous monitoring and measurement of Diclazuril residues are essential to confirm that these MRLs are not exceeded, thus upholding food safety standards and minimizing potential health risks for consumers.
2. Why Measure Diclazuril Residues?
The measurement of Diclazuril residues is a critical practice with multifaceted importance, driven by both regulatory and scientific imperatives. This rigorous measurement process is vital for several compelling reasons:
a. Regulatory Compliance: The agricultural and veterinary sectors are governed by stringent regulations and standards that aim to ensure the safety and quality of food products derived from animals. Diclazuril is classified as a veterinary drug, and its residues must comply with maximum residue limits (MRLs) set by regulatory authorities. These MRLs dictate the maximum allowable concentration of Diclazuril in animal-derived products such as meat, eggs, and milk. Accurate residue measurement is the cornerstone of regulatory compliance, as it verifies that these MRLs are not exceeded.
b. Food Safety Assurance: Diclazuril residues in animal-derived products pose potential risks to human health if they exceed the established safety thresholds. Measuring these residues is a critical control point in ensuring that the food supply remains free from harmful chemical contaminants. Accurate measurement of Diclazuril residues is, therefore, a vital component of food safety assurance, protecting consumers from potential health hazards associated with excessive exposure to this compound.
c. Consumer Confidence: Transparent and rigorous residue measurement practices are pivotal in building and maintaining consumer confidence. When consumers are assured that the food products they purchase comply with strict safety and quality standards, they are more likely to trust and support the agricultural and veterinary sectors. By demonstrating a commitment to safety through precise residue measurement, these sectors can bolster consumer confidence and promote the consumption of animal-derived products.
d. Industry Integrity: Accurate measurement of Diclazuril residues is not only a matter of regulatory compliance but also an ethical imperative. Upholding the integrity of the agricultural and veterinary industries is contingent on adherence to best practices, including responsible drug usage and residue management. Rigorous residue measurement supports this integrity by ensuring that industry players meet their obligations to protect both animal welfare and human health.
In conclusion, the measurement of Diclazuril residues is a multifaceted process with profound implications for regulatory adherence, food safety, consumer trust, and industry integrity. It exemplifies the intersection of science, regulation, and ethics in the realm of veterinary pharmacology and food production, underlining the importance of accurate and continuous monitoring to meet the demands of a globalized and discerning market.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.